Vascular Biogenics Ltd. - Ordinary Shares (VBLT): Price and Financial Metrics
Vascular Biogenics Ltd. - Ordinary Shares (VBLT)
Today's Latest Price: $1.47 USD
0.12 (8.89%)
Updated Dec 2 4:00pm
Add VBLT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
VBLT Stock Summary
- Of note is the ratio of Vascular Biogenics Ltd's sales and general administrative expense to its total operating expenses; merely 9.6% of US stocks have a lower such ratio.
- VBLT's price/sales ratio is 57.46; that's higher than the P/S ratio of 95.77% of US stocks.
- In terms of volatility of its share price, VBLT is more volatile than just 6.09% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Vascular Biogenics Ltd, a group of peers worth examining would be GRTS, SYBX, MGNX, MTEM, and KALV.
- VBLT's SEC filings can be seen here. And to visit Vascular Biogenics Ltd's official web site, go to www.vblrx.com.
VBLT Stock Price Chart Interactive Chart >
VBLT Price/Volume Stats
| Current price | $1.47 | 52-week high | $1.64 |
| Prev. close | $1.35 | 52-week low | $0.90 |
| Day low | $1.30 | Volume | 713,606 |
| Day high | $1.48 | Avg. volume | 389,237 |
| 50-day MA | $1.19 | Dividend yield | N/A |
| 200-day MA | $1.25 | Market Cap | 61.64M |
Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Company Bio
Vascular Biogenics Limited is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. The company was founded in 2000 and is based in Or Yehuda, Israel.
Loading social stream, please wait...